We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Arthrosis
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
People with long-term (chronic) shoulder disorders caused by injuries, overuse or conditions (such as arthritis) often need physiotherapy. This usually includes exercise therapy to help reduce pain, rebuild strength and make every day activities easier. However, it can be hard to stick to an exercise programme. People may stop due to pain, fear of making the symptoms worse or simply loosing motivation.
Virtual Reality (VR) is a technology that may help people say engaged with their exercise programmes by making exercises more enjoyable and interactive. When using a headset (similar to goggles), people can see and interact with a 3D virtual world. Their movement, especially their hands and arms, are shown as an ‘avatar’ (a virtual character) in this virtual world. Exercise can feel more like playing a game or engaging with tasks/challenges, rather than performing repetitive movements. This shift might help reduce focus on pain and increase motivation. VR also provides real-time feedback, helping people track their progress and adjust their movements instantly. This might lead to more accurate and consistent exercise performance and better recovery outcomes.
Before we can test whether VR exercise programmes are effective for people with chronic shoulder disorders, we firstly need to understand whether it is practical and acceptable for patients to use. This ‘feasibility’ study will therefore involve 20 patients with chronic shoulder disorders referred for physiotherapy at the Royal National Orthopaedic Hospital (RNOH) in Stanmore. Participants will take part in three VR exercise sessions at the RNOH over a three-week period. Levels of pain, quality of life and sleep quality etc will be measured before and after three weeks. Interviews will also be held up to two weeks after the final session to explore people’s experiences and thoughts towards the VR exercise programme. The results will help us decide if a larger study should go ahead.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Physical;Rehabilitation;
You can take part if:
You may not be able to take part if:
• Patients who are unable to provide informed consent • Patients who are on a waiting list for surgery and/or injections • Patients who are referred for post-operative physiotherapy • Patients with shoulder pain not originating from an MSK aetiology (such as hemiplegia or peripheral nerve injury) • Active history of seizures • Other medical conditions deemed inappropriate for patients to participate e.g. visual impairment, unstable psychiatric illnesses. • Shoulder pain associated with bone metastasis • Currently taking part in any other upper limb research study • Patients who do not adequately understand verbal explanations or written information given in English (or are not accompanied by an interpreter/family member). • Patients who do not provide informed, written consent to enter the study
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by ROYAL NATIONAL ORTHOPAEDIC HOSPITAL NHS TRUST and funded by ORTHOPAEDIC RESEARCH UK .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 69914
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
